{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:32:46Z","timestamp":1757611966710,"version":"3.44.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,3]]},"DOI":"10.7759\/cureus.91566","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T04:23:58Z","timestamp":1756959838000},"source":"Crossref","is-referenced-by-count":0,"title":["Predictors of Dual Phosphodiesterase Type 5 Inhibitor Therapy in Persons With Erectile Dysfunction and Diabetes"],"prefix":"10.7759","author":[{"given":"Arun","family":"Pande","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish","family":"Jha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KumarPrafull","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anurag","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0318908","article-title":"Prevalence and determinants of erectile dysfunction among type 2 diabetes mellitus patients at selected government hospitals in gurage zone: a cross-sectional study","volume":"20","author":"Abdlshikure SA","year":"2025","unstructured":"Abdlshikure SA, Mamo AG, Fikadu B, Seid A. Prevalence and determinants of erectile dysfunction among type 2 diabetes mellitus patients at selected government hospitals in gurage zone: a cross-sectional study. PLoS One. 2025, 20:e0318908. 10.1371\/journal.pone.0318908","journal-title":"PLoS One"},{"key":"ref2","article-title":"Assessment of erectile dysfunction and other sexual dysfunction in men with type 2 diabetes mellitus: a multicenter observational study in North India","volume":"18","author":"Gupta M","year":"2022","unstructured":"Gupta M, Tiwari A, Chandra KP, et al.. Assessment of erectile dysfunction and other sexual dysfunction in men with type 2 diabetes mellitus: a multicenter observational study in North India. Clin Epidemiol Glob Health. 2022, 18:101136.","journal-title":"Clin Epidemiol Glob Health"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/jsm.12374","article-title":"A systematic review of the psychosocial outcomes associated with erectile dysfunction: does the impact of erectile dysfunction extend beyond a man's inability to have sex?","volume":"11","author":"McCabe MP","year":"2014","unstructured":"McCabe MP, Althof SE. A systematic review of the psychosocial outcomes associated with erectile dysfunction: does the impact of erectile dysfunction extend beyond a man's inability to have sex?. J Sex Med. 2014, 11:347-63. 10.1111\/jsm.12374","journal-title":"J Sex Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/s0090-4295(97)00238-0","article-title":"The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction","volume":"49","author":"Rosen RC","year":"1997","unstructured":"Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997, 49:822-30. 10.1016\/s0090-4295(97)00238-0","journal-title":"Urology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.7572","article-title":"Canadian Urological Association guideline: erectile dysfunction","volume":"15","author":"Domes T","year":"2021","unstructured":"Domes T, Najafabadi BT, Roberts M, et al.. Canadian Urological Association guideline: erectile dysfunction. Can Urol Assoc J. 2021, 15:310-22. 10.5489\/cuaj.7572","journal-title":"Can Urol Assoc J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/cob.12316","article-title":"Obesity in older adults: effect of degree of weight loss on cardiovascular markers and medications","volume":"9","author":"Haywood CJ","year":"2019","unstructured":"Haywood CJ, Prendergast LA, Lim R, Lappas M, Lim WK, Proietto J. Obesity in older adults: effect of degree of weight loss on cardiovascular markers and medications. Clin Obes. 2019, 9:e12316. 10.1111\/cob.12316","journal-title":"Clin Obes"},{"key":"ref7","unstructured":"The real fertility crisis. (2025). Accessed. July 1, 2025: https:\/\/www.unfpa.org\/swp2025."},{"key":"ref8","article-title":"Addressing the intersecting crises of fertility decline, diabetes, obesity and erectile dysfunction: a call for integrated policy action","volume":"35","author":"Pande AR","year":"2025","unstructured":"Pande AR, Awasthi A, Singh R. Addressing the intersecting crises of fertility decline, diabetes, obesity and erectile dysfunction: a call for integrated policy action. Clin Epidemiol Glob Health. 2025, 35:102158.","journal-title":"Clin Epidemiol Glob Health"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.356236","article-title":"ESI clinical practice guidelines for the evaluation and management of obesity In India","volume":"26","author":"Madhu SV","year":"2022","unstructured":"Madhu SV, Kapoor N, Das S, Raizada N, Kalra S. ESI clinical practice guidelines for the evaluation and management of obesity In India. Indian J Endocrinol Metab. 2022, 26:295-318. 10.4103\/2230-8210.356236","journal-title":"Indian J Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.50515","article-title":"Predictors of phosphodiesterase type 5 inhibitor treatment failure in patients diagnosed with erectile dysfunction","volume":"15","author":"Albarakati M","year":"2023","unstructured":"Albarakati M, El-Tholoth HS, Alzahrani A, et al.. Predictors of phosphodiesterase type 5 inhibitor treatment failure in patients diagnosed with erectile dysfunction. Cureus. 2023, 15:e50515. 10.7759\/cureus.50515","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41443-018-0019-5","article-title":"Low dose daily versus on-demand high dose tadalafil in diabetic patients with erectile and ejaculatory dysfunction","volume":"30","author":"Bolat MS","year":"2018","unstructured":"Bolat MS, Cinar O, Akdeniz E, A\u015fc\u0131 R. Low dose daily versus on-demand high dose tadalafil in diabetic patients with erectile and ejaculatory dysfunction. Int J Impot Res. 2018, 30:102-7. 10.1038\/s41443-018-0019-5","journal-title":"Int J Impot Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002374","article-title":"Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study","volume":"72","author":"Wetzels JF","year":"2007","unstructured":"Wetzels JF, Kiemeney LA, Swinkels DW, Willems HL, den Heijer M. Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study. Kidney Int. 2007, 72:632-7. 10.1038\/sj.ki.5002374","journal-title":"Kidney Int"},{"key":"ref13","unstructured":"KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. (2013). Accessed. July 1, 2025: https:\/\/kdigo.org\/wp-content\/uploads\/2017\/02\/KDIGO_2012_CKD_GL.pdf."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad330","article-title":"Obesity, hyperfiltration, and early kidney damage: a new formula for the estimation of creatinine clearance","volume":"108","author":"Basolo A","year":"2023","unstructured":"Basolo A, Salvetti G, Giannese D, et al.. Obesity, hyperfiltration, and early kidney damage: a new formula for the estimation of creatinine clearance. J Clin Endocrinol Metab. 2023, 108:3280-6. 10.1210\/clinem\/dgad330","journal-title":"J Clin Endocrinol Metab"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2010.01839.x","article-title":"Is obesity a further cardiovascular risk factor in patients with erectile dysfunction?","volume":"7","author":"Corona G","year":"2010","unstructured":"Corona G, Monami M, Boddi V, et al.. Is obesity a further cardiovascular risk factor in patients with erectile dysfunction?. J Sex Med. 2010, 7:2538-46. 10.1111\/j.1743-6109.2010.01839.x","journal-title":"J Sex Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.858267","article-title":"The lower limit of reference of urinary albumin\/creatinine ratio and the risk of chronic kidney disease progression in patients with type 2 diabetes mellitus","volume":"13","author":"Tang WH","year":"2022","unstructured":"Tang WH, Hung WC, Wang CP, et al.. The lower limit of reference of urinary albumin\/creatinine ratio and the risk of chronic kidney disease progression in patients with type 2 diabetes mellitus. Front Endocrinol (Lausanne). 2022, 13:858267. 10.3389\/fendo.2022.858267","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-014-3369-7","article-title":"Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes","volume":"57","author":"Zoungas S","year":"2014","unstructured":"Zoungas S, Woodward M, Li Q, et al.. Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia. 2014, 57:2465-74. 10.1007\/s00125-014-3369-7","journal-title":"Diabetologia"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032782","article-title":"Vascular risk factors and diabetic neuropathy","volume":"352","author":"Tesfaye S","year":"2005","unstructured":"Tesfaye S, Chaturvedi N, Eaton SE, et al.. Vascular risk factors and diabetic neuropathy. N Engl J Med. 2005, 352:341-50. 10.1056\/NEJMoa032782","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2008.08.023","article-title":"The Wisconsin epidemiologic study of diabetic retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes","volume":"115","author":"Klein R","year":"2008","unstructured":"Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE. The Wisconsin epidemiologic study of diabetic retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology. 2008, 115:1859-68. 10.1016\/j.ophtha.2008.08.023","journal-title":"Ophthalmology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/401424-predictors-of-dual-phosphodiesterase-type-5-inhibitor-therapy-in-persons-with-erectile-dysfunction-and-diabetes","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T04:24:02Z","timestamp":1756959842000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/401424-predictors-of-dual-phosphodiesterase-type-5-inhibitor-therapy-in-persons-with-erectile-dysfunction-and-diabetes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.91566","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,9,3]]}}}